2017-07-27 14:04:41 UTC

A Selection of the Best AGA Abstracts of DDW® 2017

July 27, 2017

Read the best AGA abstracts from Digestive Disease Week, published in Gastro.

Digestive Disease Week® (DDW) 2017 featured a variety of high-quality abstracts from around the world, with 12 of the most noteworthy AGA abstracts highlighted during the Best of DDW Session. These 12 abstracts cover a range of GI topics — including fecal microbial transplant, obesity and proton pump inhibitors. You can review these abstracts in the July issue of Gastroenterology. The abstracts provide many interesting mechanistic and clinical insights and treatments for diverse digestive diseases.

The 12 highlighted abstracts include:

  • Effect of Cyclooxygenase and Epidermal Growth Factor Receptor Inhibition on Colorectal Neoplasia in Familial Adenomatous Polyposis: A Randomized Placebo-Controlled Trial.; by N. Jewel Samadder, MD, et al.
  • Per Oral Endoscopic Myotomy (POEM) Versus Pneumatic Dilatation in Therapy-Naïve Patients with Achalasia: Results of a Randomized Controlled Trial; by Fraukje A. Ponds, et al.
  • Relamorelin in Patients with Diabetic Gastroparesis: Efficacy and Safety Results from a Phase 2B Randomized, Double-Blind, Placebo-Controlled, 12-Week Study (RM-131-009); by  Michael Camilleri, MD, AGAF, et al. Dr. Camilleri is the 2003 AGA Miles & Shirley Fiterman Clinical Award recipient.
  • Bifidobacterium Dentium Upregulates Intestinal Serotonin Transporter via the JNK Pathway and Stimulates 5-HT Release; by Melinda A. Engevik, PhD, et al. Dr. Engevik is the 2017 AGA-GRG Fellow Abstract Award recipient.
  • A Lactobacillus Rhamnosus GG–Derived Protein Promotes Intestinal Development via Activation of Epidermal Growth Factor Receptor in Intestinal Epithelial Cells; by Xi Shen, et al.
  • Fecal Microbial Transplant in Irritable Bowel Syndrome and a Randomized Placebo-Controlled Trial; by Savanne Holster, et al.
  • Lack of Association between Use of Proton Pump Inhibitors and Cognitive Function in Women; by Paul Lochhead, MD, et al.
  • Detection of Barrett's Esophagus via Electronic Nose Device Analysis of Exhaled Volatile Organic Compounds in Breath Samples; by Liam Zakko, MD, et al.
  • Gastrointestinal Events in Arthritis Patients at Increased Cardiovascular Risk Treated Chronically with Celecoxib, Naproxen or Ibuprofen: The Precision Randomized, Controlled Trial; by Neville D. Yeomans, MD, AGAF, et al.
  • Obesity Is Associated with Inferior Response to Anti-Tumor Necrosis Factor Therapy in Immune-mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis; by Siddharth Singh, MD, AGAF, et al. Dr. Singh is a recipient of the 2000 AGA Miles & Shirley Fiterman Basic Research Award.
  • Maternal Immunomodulator or Biologic Use Does Not Impact Vaccine Response in Infants: Results from the PIANO Registry; by Ashwin Ananthakrishnan, MD, MPH, et al. Dr. Ananthakrishnan has received the 2011 AGA Research Scholar Award and the 2011 AGA Elsevier Pilot Award.
  • Superior Endoscopic and Deep Remission Outcomes in Adults with Moderate to Severe Crohn's Disease Managed with Treat-to-Target Approach Versus Clinical Symptoms: Data from CALM; by Jean Frederic Colombel, MD, et al.

All awards made possible through the AGA Research Foundation.

More on Barrett's Esophagus

Porcine Esophageal Submucosal Gland Culture Model Shows Capacity for Proliferation and Differentiation

Oct. 22, 2017

We describe a novel porcine 3-dimensional culture model that reproduces esophageal submucosal gland proliferation in vivo associated with cancer and injury.

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett’s Esophagus With a Minimally Invasive Cell Sampling Device

Sept. 1, 2017

We found Cytosponge screening with endoscopic confirmation to be a cost-effective strategy.

Late Recurrence of Barrett’s Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial

Sept. 1, 2017

Endoscopic surveillance of patients with BE treated with radiofrequency ablation will likely be of diminishing value as the time since ablation grows.